Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$ADPT Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.25 down -47.06% YoY • Reported revenue of $71.55M up 21.53% YoY • Adaptive Biotechnologies expects full year MRD revenue between $268 million and $278 million, while total company operating expenses, including cost of revenue, are forecast between $350 million and $355 million.

Price since post

Full Details

Advertisement|Remove ads.